← Open Payments lookup

STEVE STROMSDORFER: Open Payments

NPI 1851362479 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,189 in 98 payments from 18 companies in 2025. Trend: 2023 $1,600 · 2024 $1,665 · 2025 $2,189

Food & beverage: $2,189
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.14$329
ABBVIE INC.10$310
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$214
Corium, LLC11$185
Takeda Pharmaceuticals U.S.A., Inc.9$155
Otsuka America Pharmaceutical, Inc.9$155
Teva Pharmaceuticals USA, Inc.3$139
Axsome Therapeutics, Inc.6$133
Lundbeck LLC6$120
Neurocrine BioSciences, Inc.6$102

Products named: FANAPT, VRAYLAR, REXULTI, CAPLYTA, Azstarys, TRINTELLIX, AUSTEDO XR, Auvelity.

Industry payments across MO — which companies pay providers there.